|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.
The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by JP Morgan on 2021-03-02. The analyst firm set a price target for 15.00 expecting ORTX to rise to within 12 months (a possible 122.88% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $6.73 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Orchard Therapeutics.
There is no upcoming split for Orchard Therapeutics.